Juan Horacio Alonso-Briales

Juan Horacio Alonso-Briales

Auto-generated profile, based on publicly available information

Juan Horacio Alonso-Briales

Área del Corazón, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), Hospital Universitario Virgen de la Victoria, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Departamento de Medicina UMA, 29010 Malaga, Spain

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
FCFernando Carrasco-Chinchilla
Fernando Carrasco-Chinchilla
DADabit Arzamendi
Dabit Arzamendi
MRMiguel Romero
Miguel Romero
FCFederico Gimeno de Carlos
Federico Gimeno de Carlos
JAJuan Horacio Alonso-Briales
Juan Horacio Alonso-Briales
JLJosé Suárez de Lezo
José Suárez de Lezo

1 January 2001 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
FBFernando Cabrera Bueno
Fernando Cabrera Bueno
JDJuan Jose Gomez Doblas
Juan Jose Gomez Doblas
MRManuel Ruiz Ruiz
Manuel Ruiz Ruiz
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
IBIsabel Rodríguez Bailón
Isabel Rodríguez Bailón
EGEduardo de Teresa Galván
Eduardo de Teresa Galván

1 January 1998 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
JDJuan Jose Gomez Doblas
Juan Jose Gomez Doblas
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
IBIsabel Rodríguez Bailón
Isabel Rodríguez Bailón
JBJuan Horacio Alonso Briales
Juan Horacio Alonso Briales
JGJosé María Hernández García
José María Hernández García
FRFernando Álvarez de Cienfuegos Rivera
Fernando Álvarez de Cienfuegos Rivera

1 December 2014 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
FCFernando Carrasco-Chinchilla
Fernando Carrasco-Chinchilla
DADabit Arzamendi
Dabit Arzamendi
MRMiguel Romero
Miguel Romero
FCFederico Gimeno De Carlos
Federico Gimeno De Carlos
JAJuan Horacio Alonso-Briales
Juan Horacio Alonso-Briales
JLJosé Suárez De Lezo
José Suárez De Lezo

19 May 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
JCJuan Caballero-Borrego
Juan Caballero-Borrego
JAJuan Horacio Alonso-Briales
Juan Horacio Alonso-Briales
AMAntonio Muñoz-García
Antonio Muñoz-García
ADAntonio Domínguez-Franco
Antonio Domínguez-Franco
JMJosé María Melero-Tejedor
José María Melero-Tejedor
JHJosé M. Hernández-García
José M. Hernández-García

20 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FCFrancesco Costa
Francesco Costa
AJAlfonso Jurado-Roman
Alfonso Jurado-Roman
GCGabriele Carciotto
Gabriele Carciotto
VBVictor M. Becerra-Munoz
Victor M. Becerra-Munoz
DTDaniel Tebar
Daniel Tebar
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
Pulmonary embolism (PE) is a life-threatening medical condition caused by the thrombotic occlusion of one or more branches of the lung vasculature, which represents the third most common cause of cardiovascular mortality after myocardial infarction and stroke. PE treatment requires a tailored approach based on accurate risk stratification and personalized treatment decision-making. Anticoagulation is the cornerstone of PE management, yet patients at higher clinical risk may require more rapid reperfusion therapies. In recent years, transcatheter treatment has emerged as a valuable option for patients with intermediate–high or high-risk PE who have contraindications to systemic thrombolysis. Recent advancements in catheter-directed therapies, such as catheter-directed thrombolysis (CDT) and catheter-directed mechanical thrombectomy (CDMT), provide minimally invasive options for swift symptom relief and hemodynamic stabilization. This review aims to provide a practical approach for optimal patient selection and management for PE percutaneous therapies, supported by a thorough evaluation of the current evidence base supporting these procedures. A focus on post-procedural management, the prevention of recurrence, and monitoring for long-term complications such as chronic pulmonary hypertension and post-PE syndrome is also specifically tackled.